Product Code: ETC12010841 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Drug Eluting Cardiovascular Devices Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Drug Eluting Cardiovascular Devices Market - Industry Life Cycle |
3.4 Mexico Drug Eluting Cardiovascular Devices Market - Porter's Five Forces |
3.5 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.6 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Mexico Drug Eluting Cardiovascular Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Mexico |
4.2.2 Technological advancements in drug-eluting cardiovascular devices |
4.2.3 Growing adoption of minimally invasive procedures in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-eluting cardiovascular devices |
4.3.2 High cost associated with drug-eluting cardiovascular devices |
4.3.3 Limited reimbursement policies for these devices in Mexico |
5 Mexico Drug Eluting Cardiovascular Devices Market Trends |
6 Mexico Drug Eluting Cardiovascular Devices Market, By Types |
6.1 Mexico Drug Eluting Cardiovascular Devices Market, By Device Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Device Type, 2021 - 2031F |
6.1.3 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Drug-Eluting Stents, 2021 - 2031F |
6.1.4 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Drug-Coated Balloons, 2021 - 2031F |
6.1.5 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Implantable Drug-Eluting Devices, 2021 - 2031F |
6.1.6 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Bioabsorbable Stents, 2021 - 2031F |
6.2 Mexico Drug Eluting Cardiovascular Devices Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Coronary Artery Disease, 2021 - 2031F |
6.2.3 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Peripheral Artery Disease, 2021 - 2031F |
6.2.4 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Pulmonary Hypertension, 2021 - 2031F |
6.2.5 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Other Cardiovascular Disorders, 2021 - 2031F |
6.3 Mexico Drug Eluting Cardiovascular Devices Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Cardiology Centers, 2021 - 2031F |
6.3.4 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.5 Mexico Drug Eluting Cardiovascular Devices Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
7 Mexico Drug Eluting Cardiovascular Devices Market Import-Export Trade Statistics |
7.1 Mexico Drug Eluting Cardiovascular Devices Market Export to Major Countries |
7.2 Mexico Drug Eluting Cardiovascular Devices Market Imports from Major Countries |
8 Mexico Drug Eluting Cardiovascular Devices Market Key Performance Indicators |
8.1 Number of hospitals/clinics adopting drug-eluting cardiovascular devices in Mexico |
8.2 Patient outcomes and success rates post-procedure using drug-eluting cardiovascular devices |
8.3 Research and development investment in new drug-eluting cardiovascular device technologies. |
9 Mexico Drug Eluting Cardiovascular Devices Market - Opportunity Assessment |
9.1 Mexico Drug Eluting Cardiovascular Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.2 Mexico Drug Eluting Cardiovascular Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Mexico Drug Eluting Cardiovascular Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Mexico Drug Eluting Cardiovascular Devices Market - Competitive Landscape |
10.1 Mexico Drug Eluting Cardiovascular Devices Market Revenue Share, By Companies, 2024 |
10.2 Mexico Drug Eluting Cardiovascular Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |